Observational study on quality of life, safety, and effectiveness of first‐line cetuximab plus chemotherapy in
KRAS
wild‐type metastatic colorectal cancer patients: the ObservEr Study
Keyword(s):
2017 ◽
Vol 16
(2)
◽
pp. e29-e37
◽
Keyword(s):
Keyword(s):
2018 ◽
Vol 36
(15_suppl)
◽
pp. 12007-12007
◽